Curis | CRIS - Ebitda





Ebitda تغيير تاريخ
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 12.14B 4.26B 2025-12
Exelixis USD 258.29M 15.43M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Incyte USD 367.97M 46.53M 2026-03
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Takeda JPY 150.25B 297.88B 2026-03
TG Therapeutics USD 51.69M 19M 2025-12
Xoma USD 2.52M 7.98M 2024-06